ALGS vs LW · rev $3.6M vs P/E 21, rev $6.45B
Aligos Therapeutics Inc (ALGS) versus Lamb Weston Holdings Inc (LW) — a side-by-side from cached financials, not a winner call.
Aligos Therapeutics Inc (ALGS) is a biotechnology company listed on US.
Lamb Weston Holdings Inc (LW) is a packaged foods company listed on US.
Latest reported ALGS revenue for 2024-12-31 was $3.6M. Net income was -$131.2M. Revenue was down 41.7% from 2023-12-31 to 2024-12-31. ALGS currently screens at market cap $44.1M.
Latest reported LW revenue for 2025-05-25 was $6.45B. Net income was $357.2M. Revenue was down 0.3% from 2024-05-26 to 2025-05-25. LW currently screens at market cap $7.40B and trailing P/E 20.6.
ALGS currently screens at market cap $44.1M. LW currently screens at market cap $7.40B and trailing P/E 20.6.
Not investment advice. Open the ALGS and LW stock pages for the full models.
Not investment advice.